Members
of the superfamily of nuclear receptors share the greatest homology in their DNA-binding domains. We have used reverse transcription-polymerase chain reaction and highly degenerate primers based on the amino acid sequence of the zinc finger motif of known nuclear receptors to identify novel members of the family. Starting with rat brain RNA, we have isolated an orphan receptor that we call RZR/3. The sequence of its nearly full-length complementary DNA shows great similarity to RZRa, a receptor we recently identified from human umbilical vein endothelial cells. These RZR subtypes represent members of a new family of orphan nuclear receptors that most likely regulate specific gene expression.
Sequence comparison with other known nuclear receptors reveals great similarity for both RZR subtypes to retinoic acid and retinoid-X receptors. By Northern blot analyses, we found RZRP messenger RNA only in brain, whereas RZRa is expressed in many tissues. We show here that the RZRs bind as monomers to natural retinoid response elements formed by (A/G)GGTCA half-sites. However, a T-residue in the -1 position of this motif greatly enhances the DNA binding affinity of RZRs, whereas the -2 position has no influence. We show that RZRs can bind as homodimers on response elements formed by palindromes, inverted palindromes, or direct repeats of two TAGGTCA halfsites. Interestingly, these response elements display dramatically reduced affinity for retinoic acid receptor-retinoid-X receptor heterodimers. Thus, the 5'-flanking sequence of hexameric half-sites appears to be crucial to direct the activity of several nuclear receptors. On monomeric as well as dimeric binding sites, RZRs show constitutive transactivational activity that can be enhanced by unidentified
INTRODUCTION
Retinoids, vitamin D, and thyroid and steroid hormones regulate a number of developmental and physiological processes in vertebrates as well as invertebrates by binding to specific receptors that function directly as transcription factors. These ligand-dependent transcription factors are part of the superfamily of nuclear receptors (1, 2) . In addition to these receptors, other members of the family are structurally related proteins for which no ligand has been identified and, therefore, are referred to as orphan receptors (3) . Recently, the retinoid-X receptor (RXR) orphan receptor family (4, 5) was shown to bind 9-cis retinoic acid (RA), suggesting that a ligand may indeed exist for these receptors (6, 7). Moreover, this family has been found to interact with thyroid hormone receptors (TSR), vitamin D receptors (VDRs), the peroxisomal proliferation activator receptors, as well as the closely related RA receptor (RAR) family members (8-l 4). However, other orphan receptors, such as chicken ovalbumin up-stream promotertranscription factor (COUP-TF), which also interacts with the RAR family (1.5) as well as other receptors (16, 17) may not be activated by a ligand. Instead, its phosphorylation state may regulate the activation of COUP-TF as a transcription factor. Another recently discovered orphan receptor, nerve growth factor-induced clone 6 (NGFI-B), appears to be regulated principally by its expression; its transcript is induced by ACTH (18).
The majority of nuclear receptors contain three principal protein domains: a variable amino-terminal domain often encoding transactivating activity, a highly conserved DNA-binding domain, and a moderately conserved carboxy-terminal ligand-binding domain. The
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MOL END0.1994 Vol8 No. 6 758 DNA-binding domain is composed of two zinc finger motifs. Differences in the sequence of the zinc-finger motifs between receptors have been associated with differences in DNA binding and receptor dimerization or its absence (19) (20) (21) . Furthermore, studies on the DNAbinding domain of RXR and NGFI-B (=Nur77) have suggested that a region immediately carboxy-terminal of the zinc fingers also participates in DNA recognition (22, 23 ). This region is formed by two adjacent clusters of amino acids, referred to as the A-and T-boxes. These amino acids appear to play an important role in binding of the receptor to DNA and its potential for dimerization. Differences in these regions of the receptors also correlate with a division of the superfamily into four different groups: I) receptors that act as homodimers, such as steroid hormone receptors (24, 25); II) T3Rs, VDRs, and RARs, which act as both homodimers (26-29) and heterodimers (8-14); Ill) the NGFI-B, fushi tarazu factor 1, and Rev-ErbAcu (=EARl) receptors, which appear to function uniquely as monomers (22, 30, 31); and IV) the peroxisomal proliferation activator receptors and ecdysone receptor, which bind exclusively as heterodimers (32-35).
Nuclear receptors bind to DNA sequences in the promoter of target genes, referred to as response elements. The response elements assigned to the members of groups I and II consist of two half-site sequence motifs related to either AGAACA or AGGTCA sequences. The relative orientation and spacing of these half-sites play essential roles in the selection of receptors binding the response elements. In contrast, response elements of the orphan receptors of group III appear to be based on only one half-site motif, AGGTCA, preceded by a few nucleotides, which appear to specify the specific orphan receptor that binds (36).
The universal presence of conserved amino acids in the DNA-binding domain of all superfamily members allows a number of molecular approaches to identifying new members of the family. We chose to amplify sequences encoding the DNA-binding motif of these receptors from RNA sources by reverse transcriptionpolymerase chain reaction (RT-PCR). To enable the potential cloning of all members of the superfamily present in the source tissue or cell line, we used highly degenerate primers designed from the conserved zinc finger domain sequences. Applying this approach to endothelial cells, we recently identified a novel orphan receptor, which we called RZRa (37). Here we describe the isolation of a second brain-specific member of this family of retinoid-related receptors, referred to as RZRP. These receptors bind to DNA as monomers, but, interestingly, they are also able to form homodimers on selected response elements.
RESULTS

RT-PCR Identifies Two Novel Orphan Receptors Expressed in Rat Brain
To identify novel members of the nuclear receptor superfamily expressed in the brain, we used a RT-PCR protocol previously described for human umbilical vein endothelial cells (HUVECs) (37). We chose to dissect five different brain tissues (caudate putamen, cerebellum, cortex, hippocampus, and thalamus) to test for the presence of novel receptors. RNA extracted from these dissected tissues was used for the amplification of nuclear receptor DNA-binding domains. Among the 17 different nuclear receptor complementary DNAs (cDNAs) that we isolated, two are novel orphan receptors (data not shown). We found cDNAs corresponding to these two receptors in all five brain area RNAs at varying relative concentrations.
We have named one of the novel receptors TR2-RI for its homology to TR2, the testis-and prostate-specific orphan receptor (38). Despite the discovery of TR2 in the testes, its relative (TR2-Rl)
is the most abundant species of nuclear receptor cDNA found in all areas of the brain that we examined. We did not study this receptor any further, as it appears to belong to a family that has previously been described by others. We also identified another novel receptor, which we have called RZRP. We named this receptor for its homology to the RZRL~ receptor that we isolated from HUVECs. RZRQ and RZRB appear to define a new family, which we characterize further in the next section.
Cloning of Nearly Full-Length cDNA Clones Encoding RZRCX and RZRP Reveals a New Family of Nuclear Receptors
To further characterize the novel receptor RZRB, we isolated cDNAs encoding the entire protein. First, a set of specific primers for amplification of the cDNA 3'-end [rapid amplification of cDNA ends (RACE protocol)] (39) was designed based on the sequence of the PCRgenerated cDNA fragments. Starting with RNA from total rat brain, we isolated 3'-cDNA clones for RZRP. These clones encoded the amino acid sequence between the second zinc finger domain and the C-terminus. To identify a full-length RZR/3 cDNA clone, we used the 3'-RACE-generated fragment as a hybridization probe on cDNA libraries from several rat brain tissues (hippocampus, hypothalamus, and cortex). A total of 22 independent RZRP-hybridizing cDNA clones were identified. For the 10 longest clones, the sequence extends approximately 400 nucleotides 5' of the first zinc finger motif and encodes methionine and stop codons in all three reading frames. We believe that this sequence is part of a fully processed transcript for three reasons. 1) PCR experiments using specific primers derived from this up-stream sequence failed on genomic DNA (data not shown), suggesting that this up-stream sequence is not continuous, i.e. not an intron. 2) We cloned and sequenced chicken RZR@ cDNA (data not shown). This cDNA also commences with a long 5'-untranslated region encoding methionine and stop codons in all three frames. However, there is not much similarity between the chicken and the rat 5'-untranslated region, nor are any potential 3'-splice acceptor sites conserved.
3) The only sequence motifs con- served between the 5'-untranslated regions of chicken and rat RZRP bear strong resemblance to internal ribosome entry site motifs (40, 41) identified in 5'-untranslated regions of some picorna virus genes. Thus, RZRP messenger RNA (mRNA) may be translated by internal entry of ribosomes, rather than by a scanning mechanism. Therefore, we suggest that RZRP starts with the methionine that is shared with RZRa ( Fig. 1) .
To compare the sequence homology between the RZR members themselves and other members of the nuclear receptor superfamily, we aligned their deduced amino acid sequences.
These comparisons indicate that RZRa and RZRP show a domain organization shared by all other members of the nuclear receptor superfamily and that they are very closely related to each other. As expected, the best-conserved sequences are found in the DNA-binding domain, where RZRcv and RZRP share 92% identity in amino acid residues ( Figs. 1 and 2A) . However, the putative ligandbinding domain is less well conserved between RZRa and RZRP (62%). From these data we conclude that they are different rnembers of the same family. These receptors also bear high homology in their DNA-binding regions to Rev-ErbAa (31) and to the Drosophila receptor DHR3 (42). RZRP and the DHR3 receptor share 78% identity in the binding domain, whereas their ligand-binding domain identity is 35%. The functional relationship between DHR3 and the RZRs is unclear at this time.
The RZRs also bear considerable resemblance to the retinoid-binding receptors RARs and RXRs. Through their DNA-binding domains, they are highly related to RARa (RZRa, 70%; RZRP, 67%) and RXRa (65% and 62%, respectively). Due to this high degree of homology, we consider these novel receptors to be related to retinoid receptors, hence their name.
Organ Distribution of RZRP-Specific Transcripts
We wished to determine whether RZRP is more widely distributed in the body than the tissue in which we identified it. We used the RZRP cDNAs as probes of organ-specific RNA in a Northern blot analysis. Among the tissues we examined, the RZRP gene appears to be uniquely expressed in brain (Fig. 3) . Most of the RZRP hybridization signal is found in a large transcript of approximately 10 kilobases (kb). A minor fraction of the RZRP-specific transcripts is about 2.4 kb in size. Using a competitive PCR protocol (43) we estimated the amount of RZRP mRNA in total RNA extracted from rat brain tissue to be about 3 pg/pg (data not shown). Spleen RNA also has RZRB-specific transcripts that are, however, too small (-1 kb in size) to encode the peptide deduced from the brain-derived cDNAs. Longer exposure of the RNA blot to film revealed the presence of this short transcript in all of the organs examined, but at much lower levels. We have not further characterized these shorter transcripts. From our results, however, we can conclude that the species of RZRP transcript that we isolated from brain is principally, if not exclusively, expressed in the brain.
RZRcv also has a very large transcript (-15 kb) that is present in different tissues. However, in a subset of tissues, additional bands (7.5, 5.5, 2. I III  III  IIIIII  II I II II I  I  III  II  IIll/  III1  I  I III  I  I  I I  I III  II  II with RZRs are boxed. Alignments were made using the GCG computer program Bestfit.
(RORa) described by V. Giguere (GenBank accession no. U04897, U04898, and U04899). The RZRcv cDNA clone differs from all three RORa cDNA isoforms by its N-terminal sequence preceding the first zinc finger. Therefore, RZRcv can also be considered a fourth Nterminal variant of RORo(. The complex band pattern observed in Northern blot hybridization experiments could be the basis for the different N-terminal-splicing variants of RoR~u/RzRcu.
RZRs Bind as Monomers to RA Response Elements
As a first approach, we compared the amino acid sequence of the RZR DNA-binding domain with that of other receptors in an attempt to predict the DNA interactions based on analogy to homologous receptors. Comparing the P-box sequences for different receptors shows that RZRs (EGCKG) belong to the same subclass of nuclear receptors as RARs, RXRs, T3Rs, and VDRs (19, 44). In addition, RZRs and retinoid receptors share high homology throughout their DNA-binding domains Therefore, we asked whether RZRs would bind to known retinoid receptor response elements. In vitro translated RZRcv (data not shown), RZRP, and a mixture of RARa and RXRa were used in mobility shift assays to test their binding to DNA fragments containing different RA response elements (Fig. 4) . We used the RA response elements of the human alcohol dehydrogenase (DR5& gene 3 (45) the mouse cellular retinol-binding protein-l (DR2CRBPI) gene (46) the human RARB (DR&& gene (47) the mouse -yF-crystallin (IPgSFCRY) gene (48) an idealized form of the element from the rat GH (POTRE.& gene (49) and a palindrome of two (A/G)GGTCA half-sites (PO) (29). On all of these elements the binding efficiency of RARoc/RXRa heterodimers appeared greater than that of RZRn or -p. In particular, response elements formed by (A/G)GTTCA half-sites (DR!jRnRd and PO) were less efficiently bound by RZRs than those formed by (A/G)GGTCA half-sites.
DNA complexes containing RZRs exhibit a significantly higher mobility than DNA complexes made up of RAR/RXR heterodimers.
However, RZRs and retinoid 5) . The response elements containing the 5'-flanking sequences AT, CT, GT, and TT are more efficiently bound than any of the other sequences. Thus, a T at -1 to the (A/ G)GGTCA core motif is critical, whereas all four nucleotides are approximately equal in binding efficiency when present in the -2 position.
To quantify this effect, we performed Scatchard binding analysis on the complexes of the electrophoretic mobility shift assay. RZRU bound to the probes AT and GT with dissociation constants (K,,) of 1.8 and 1.9 nM respectively, whereas RZRP gave Kd values of 1.7 and 1.6 nM on these response elements (Fig. 6) . These K,, values represent physiologically relevant affinities similar to those of T,Rs or NGFI-B for their DNA elements (22, 50). In contrast, the probes AG and GG gave Kd values of 13.7 and 11.6 nM for RZRa and 14.2 and 12.3 nM for RZRP (Fig. 6) . The Kd values of RZRcv and -p binding are very similar to each other for the four elements examined. These results support the conclusion that the two subtypes bind response elements with similar affinities.
To measure transcriptional activity of the RZR receptors on these response elements, we fused the same oligomers to the thymidine kinase (tk) promoter driving the chloramphenicol acetyltransferase (CAT) gene. As Drosophila cells are devoid of mammalian nuclear receptors by definition, we chose to carry out our studies of RZR activity in the SL-3 Drosophila line. However, we observed basal CAT activity on some of the response elements, even if only an empty expression vector was cotransfected with the reporter vector. This is probably due to endogenous Drosophila nuclear receptors that bind as monomers and activate the reporter gene. Therefore, we subtracted these basal values from the CAT activities measured when expression vectors for the RZRs were cotransfected with the reporter vector. The corrected CAT activities on each response element were then compared with the basal activity of the tk promoter. Increases in reporter activity of up to 30-fold were measured (Fig. 5) . These strong responses seen in the absence of added ligand suggest that the RZRs may act in a constitutive, rather than inducible, manner.
The transactivation data closely parallel the DNA binding efficiencies of RZRs for each of the 16 monomer response elements. These results suggest a direct correlation between efficient binding as monomers and transactivation.
Furthermore, the patterns of both DNA binding and transactivation appear to be identical for RZRcv and RZRP. Previously, we made a similar observation for the three RAR subtypes: (Y, p, and y (28). The apparent higher absolute transactivation seen with RZRP compared to that with RZRa may be due to different levels of expression for the two RZR receptors in the SL3 cell line.
RZRs Form Homodimers
We wished to determine whether RZRs could only bind as monomers or as both monomers and homodimers as TR3 does (26). We designed response elements containing two TAGGTCA half-sites oriented as direct repeats (DR), palindromes (P), or inverted palindromes (IP). To avoid confusion, we retained the numbering system established for spacing between hexameric half-sites. Oligomer nucleotides comprising these response elements were used in both gel mobility shift experiments and fused to the tk promoter for transactivation analyses. This allowed us to compare directly RZRP activity on the dimeric response elements with its activity on the monomer-binding site (Fig. 7) . A second specific protein-DNA complex migrating at the position of a putative receptor dimer can be seen in the mobility shift assays. We found this complex on response elements DR7, DR8, DR9, PO, P3, and IPlO, whereas with DR2 and DR5, only a very faint band corresponding to the dimer could be observed. Response elements that contained only one half-site showed only one complex migrating as a monomer. In general, the ratio of dimer to monomer complexes appears to be dependent on the relative orientation and spacing of the two half-sites. The response elements PO and DR8 bind the putative RZR homodimer most efficiently (Fig. 7A) . Using Scatchard analysis, we determined K,, values of 0.5 and 0.7 nM, for the dimeric response elements PO and DR8, respectively. These values are significantly lower than those calculated for the monomer sites. Moreover, functional transactivation data correlate well with the binding affinities (Fig. 7A) . The fold induction over basal levels on the PO and DR8 elements was more than twice that of the similar monomer site. These results suggest a synergistic or cooperative action of the RZR homodimers. To ascertain whether dimeric response elements are bound either independently by two receptor monomers or cooperatively by a homodimer, we performed cooperativity assays. Increasing amounts of in vitro translated RZRP were added to a constant amount of labeled DNA fragments, and the formation of monomeric or dimeric complexes was quantified by gel retardation analysis. Figure 7B demonstrates that RZRs bind with positive cooperativity, because the monomeric complexes reach a lower plateau value than dimeric complexes, which generally did not plateau. Relative differences in cooperativity are reflected by differences between the monomer and dimer curves. From this analysis, the PO element shows the greatest cooperativity.
RZRs and Retinoid Receptors Differentiate Their Respective Response Elements by the 5'-Preceding Nucleotide
The response elements shown in Fig. 7 resemble the natural and artificial RA response elements used in Fig.  4 . In particular, direct repeats spaced by two and five nucleotides (DR2 and DR5) should principally bind retinoid receptors. We wished to determine whether there is an interference in binding or transactivation if RZRs and retinoid receptors are both present. We hypothesized that the 5'-preceding nucleotide would determine specific receptor binding to each of the two half-sites. Therefore, we expanded our set of DR2-and DR5-type response elements to include either G, A; G, T; T, A; or T, T in the two -1 positions of the direct repeats. We then measured the potential of these response elements for inducing the fused reporter gene in the presence of either RZRP or RARcu/RXRa with or without all-trans-RA as a ligand.
In this assay, RARa/RXRcu heterodimers also show a low constitutive activity (Fig. 8) . However, the addition of all-Vans-RA results in a strong induction of reporter activity, but only on those response elements where both half-sites are preceded by a purine. The absolute as well as the relative induction of CAT activity were significantly less if these positions were occupied by Tresidues. A thymidine preceding the first core half-site reduced the reporter activity less than one preceding the second response element. T-Residues preceding both half-sites resulted in only residual retinoid receptor activity. These results closely parallel the DNA binding studies performed with in vitro translated RARcu/RXRa on the eight oligomers carrying the same nucleotide sequences (Fig. 8) . The most efficient binding of RARa/ RXRa was seen with the response elements preceded by a purine, and the least efficient occurred when the elements were both preceded by thymidines.
In contrast, RZRP acting on this set of response elements gave nearly opposite results (Fig. 8) . Neither significant transactivation nor DNA binding affinity of RZR/3 could be detected when both -1 positions were occupied by purines. Rather, RZRP was most effective when a T-residue preceded the second half-site in the response elements. Thus, RZR and RARa/RXRcu dimers favor different sequences for their binding and transactivation in vitro. This discrimination of response elements may be the case in vivo as well, providing a mechanism for selecting a particular receptor for the regulation of responding genes based on their specific retinoid response elements. Experimental evidence in favor of this idea is provided by competition studies between RZR and RAR/RXR on two native response elements. We tested the abilities of different ratios of these receptors to stimulate either the mouse cellular retinol-binding protein-l (CRBPI) gene (46) (DR2CRBP, = DR2TA in Fig. 8 ) or the human RARP gene (47) (DR5RARp) RA element in the presence of the ligand for RAR/RXR, all-frans-RA (Fig. 9) . As can be seen, RZRP competes with the RAR/RXR heterodimer for activation of the CRBPI response element. In a titration series with increasing ratios of RZRP vs. RAR/RXR, the RA-dependent response is lowered to RA-independent RZR& specific values. In contrast, the RA response element of the human RARP gene is much more refractory to competitive titration with RZRP (Fig. 9) . A significant difference between the two naturally occurring re- sponse elements is the presence of a T-residue preceding the half-site in the CRBPI promoter, but not the RARP half-site. A simple explanation for the difference in responses would be the ability of RZR to bind to the CRBPI but not to the RARP promoter. In vivo, however, the situation may be more complex, because other proteins of the transcription complex may stabilize the RZRs and retinoid receptors on suboptimal response elements. sulted in even higher levels of reporter gene induction in the presence of RZRs. To evaluate at least the most common ligands of receptors related to the RZRs, we tested thyroid hormone (T3) and all-Vans-and 9-cis-RA for their ability to augment the activity of RZRs on either a monomer or a homodimer binding site (Fig. 10) . None
Monomer Dimer of these ligands (nor their potential metabolites) caused any increased activity compared to the noninduced constitutive case. Surprisingly, the exclusion of fetal calf serum (FCS) from the cultures caused a 3-fold decrease in the transaction by RZRa (data not shown) and RZRP on both monomer and dimer response elements. It is not known whether a component of the serum acts directly on these receptors, or serum has an indirect effect, such as inducing phosphorylation of the receptors. However, we are continuing our experiments to determine whether a ligand/activator of RZRs can be identified.
DISCUSSION
Members of the nuclear receptor superfamily, including the orphan receptors, are expressed with overlapping tissue and developmental distribution. In addition, they show overlapping specificities of interaction with response elements of target genes. Thus, the complement of family members in a given tissue may provide an interactive level of regulation of specific target genes and would be expected to play a major role in programming tissue-specific expression. The observation that almost all members of the superfamily whose tissue distribution has been examined to date are expressed in brain tissue provides an excellent opportunity to examine the complexity of the superfamily. With our PCR method, we generated sequences of known and novel receptors as well as measurement of their relative 20 60 expression in different brain tissues. Here we report the isolation and characterization of a novel member of the nuclear receptor superfamily. The identification of a second receptor, called RZRP, with high homology to the previously isolated RZRcv provides evidence for the existence of an additional family within the nuclear receptor superfamily (37). Unlike RZRcu, RZRP appears to be predominately located in brain tissue, suggesting a primary role for this receptor in regulating gene expression in the central nervous system. A similar relation was recently reported for NGFI-B (=Nur77) and its brain-specific family member, NURRl (51). We have chosen the designation RZRs (for retinoid-Z receptor) because of the homology they bear to retinoid receptors; however, their ultimate classification should conform to the natural ligand's identity.
We have shown that RZRs are sequence-specific DNA-binding proteins and transcriptional activators. They bind as monomers to natural and artificial RA response elements containing hexameric (A/G)GGTCA half-sites. These half-sites may be the primordial DNAbinding elements for the nuclear receptor superfamily. Thus, the ability of a receptor to recognize and bind different variants of (A/G)GGTCA half-sites may be critical to its function. Classical receptors, such as RARs, RXRs, and T3Rs, control specific gene regulatory networks by distinguishing between different organizations of receptor response elements. However, the detailed mechanisms for such a selectivity is not yet well understood.
In this respect, our findings that the DNA binding affinity of RZR monomers could be significantly enhanced by a T-residue in the -1 position of the (A/G)GGTCA core motif and that on some response elements containing two half-sites with this modification, RZRs bind cooperatively as homodimers, suggest such a mechanism.
Most classical nuclear receptors do not bind to DNA sequences that contain a single half-site, because the interaction of one monomer with one half-site does not provide sufficient free energy to stabilize the protein-DNA complex. T,Rs are an exception, as they bind to their DNA elements as both monomers and dimers. However, the significance of their binding as monomers in viva is unknown. In contrast, some orphan receptors are known to bind to their response elements exclusively as monomers (e.g. NGFI-B and fushi tarazu factor 1) whereas others are known to bind as homo-or heterodimers (e.g. COUP-TFs and RXRs). Yet, none of the orphan receptors has been described to bind as both monomers and dimers. To our knowledge, RZRs are the first orphan receptors shown to have this orphan receptors shown to have this property.
Transactivation by RZRs appears to be constitutive. Well described ligands, such as T3 and all-trans-and 9-cis-RA, do not augment the transactivation measured in their absence. However, some component of serum appears to have an effect by either direct or indirect means, such as phosphorylation events. On response elements in which RZRs bind cooperatively as homodimers, transactivation is synergistically increased. We have not found heterodimerization of RZRs with other nuclear receptors, such as RAR, RXR, TSR, or COUP-TF (data not shown). However, we cannot exclude that potential heterodimers would form on response elements with different spacings than those we tested.
Due to the clear preference of RZRs for (A/G)GGTCA motifs preceded by a T, they do not bind well to the natural RA response elements we tested. With the exception of the CRBPI gene's response element (46) the known natural RA response elements do not have this 5'-flanking nucleotide. Competition between retinoid receptors and RZRs for the same binding sites, as is the case for COUP-TFs (16, 17), is, thus, less likely for most of the known RA-responding genes. However, we cannot rule out that there is cross-talk between RZRs and retinoid signaling on genes yet to be identified that are transcriptionally regulated by RA response elements similar to that of the CRBPI gene. Conversely, we could show that retinoid receptors are not active on binding sites preferred by RZRs. This reciprocal exclusion suggests that limiting response elements to hexameric core motifs is somewhat oversimplistic.
Additional information needed to discriminate the binding of specific receptors appears to be encoded by the 5'-preceding nucleotide.
The isolation of new members of the superfamily of nuclear receptors opens the possibility of discovering new pathways of regulation. Transactivation by novel receptors may be regulated by a variety of mechanisms, including synthesis/degradation, phosphorylation, and ligand binding. However, the most important challenge now is to determine the biological role of novel receptors, such as the RZRs. To begin this work we are studying the cellular expression of the RZR subtypes and searching for their natural response genes as well as for their potential native ligand. These studies may well identify a role for RZRs in specific and more general regulation of gene expression.
MATERIALS AND METHODS
RNA Isolation, RT-PCR, and Northern Blot Hybridization
Total RNA was extracted from various dissected brain areas from adult female rats according to the procedure previously described (52). RT-PCR was performed as described previously (37). A multiple tissue Northern blot (Clontech, Palo Alto, CA) containing 2 pg poly(A)' RNA isolated from various human organs was hybridized to multiprime-labeled (Stratagene, La Jolla, CA) cDNA probe in the buffer used for oligonucleotide probes (37). After overnight hybridization at 60 C, the membrane was washed under stringent conditions and autoradiographed for 16 h at -70 C using two intensifying screens. To confirm the presence of poly(A)+ RNA on each lane of the multiple tissue Northern blot, we routinely stained the RNA with methylene blue before hybridization.
Library Screening
The X-phage cDNA libraries (Stratagene) derived from rat hypothalamus and hippocampus, respectively, were screened with a multiprime-labeled (Stratagene) 3'-RACE-generated cDNA probe containing the putative ligand-binding domain and 
